Ponatinib
Approved, for something elseMeasured in people, not heightBy mouthSmall molecule
A leukaemia drug that blocks the receptor slowing cartilage growth, among many other targets.
A leukaemia drug, and a type II kinase inhibitor: it binds FGFR3 in its inactive, DFG-out conformation. It hits this receptor among many others. Oncology only.
Risks. Its label carries the strongest class of warning, for blocked arteries, blood clots, heart failure and liver damage.
On this page
- At the growth plate, members only
- Risks and side effects, members only
The rest of this page is for members
What has been measured, in whom, with every source, and what it does to the rest of you. And every article in the library.
Join for $11.99Lifetime · 3 of 10 founding spots left
Tax is added at checkout (VAT/GST where it applies).
Renews every month at the current price plus tax until you cancel. Cancel from your account before the next monthly charge to stop it.
Card purchases are sold and charged by Link (Stripe) under Link's terms and refund policy.
Already a member? Sign in
Educational content, not medical advice. Nothing here is a recommendation to take or stop taking anything — talk to a doctor about your own situation.